Inhibition of Hepatitis B Virus cccDNA by siRNA in Transgenic Mice

Cell Biochemistry and Biophysics

Volumn 69, Issue 3, 2014, Pages 649-654

  Li, Guiqiu ^a   Jiang, Guotao ^a   Lu, Juan ^a   Chen, Shulan ^a   Cui, Lanying ^a   Jiao, Jundong ^a   Wang, Yongchen ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

cccDNA; Hepatitis B virus; RNA interference; siRNA; Transgenic mice

Indexed keywords

HEPATITIS B VIRUS; MUS MUSCULUS;

CIRCULAR DNA; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; MESSENGER RNA; SMALL INTERFERING RNA; VIRUS DNA;

ANIMAL; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; HEPATITIS B VIRUS; IMMUNOLOGY; METABOLISM; MOUSE; PHYSIOLOGY; TRANSGENIC MOUSE; VIRUS REPLICATION;

ANIMALS; DNA, CIRCULAR; DNA, VIRAL; GENE EXPRESSION REGULATION; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; MICE; MICE, TRANSGENIC; RNA, MESSENGER; RNA, SMALL INTERFERING; VIRUS REPLICATION;

EID: 84902363781     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-014-9847-1     Document Type: Article

References (25)

1. Seeger, C., & Mason, W. S. (2000). Hepatitis B virus biology. Microbiology and Molecular Biology Reviews, 64, 51-68.
2. Beasley, R. (1998). Hepatitis B virus: The major etiology of hepatocellular carcinoma. Cancer, 61, 1942-1956.
3. Parkin, D. M., Pisani, P., Munoz, N., et al. (1999). The global health burden of infection associated cancers. Cancer Surveys, 33, 5-33.
4. Rabe, C., Cheng, B., & Caselmann, W. H. (2001). Molecular mechanisms of hepatitis B virus-associated liver cancer. Digestive Diseases, 4, 279-287.
5. Dienstag, J. L., Cianciara, J., Karayalcin, S., et al. (2003). Durability of serologic response after lamivudine treatment of chronic hepatitis B. Hepatology, 37, 748-755.
6. Lin, O. S., & Keeffe, E. B. (2001). Current treatment strategies for chronic hepatitis B and C. Annual Review of Medicine, 52, 29-49.
7. Nowak, M. A., Bonhoeffer, S., Hill, A., et al. (1996). Viral dynamics in hepatitis B virus infection. Proceedings of National Academy of Sciences, 93, 4398-4402.
8. Zoulim, F., & Trepo, C. (1998). Drug therapy for chronic hepatitis B: Antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy. Journal of Hepatology, 9, 151-168.
9. Hannon, G. J. (2002). RNA interference. Nature, 418, 244-251.
10. Fire, A., Xu, S., Montgomery, M. K., et al. (1998). Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature, 391, 806-811.
11. Dykxhoorn, D. M., Novina, C. D., & Sharp, P. A. (2003). Killing the messenger: Short RNAs that silence gene expression. Nature Reviews Molecular Cell Biology, 4, 457-467.
12. Lee, N. S., Dohjima, T., Bauer, G., et al. (2002). Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nature Biotechnology, 20, 500-505.
13. Kapadia, S. B., Brideau-Andersen, A., & Chisari, F. V. (2003). Interference of hepatitis C virus RNA replication by short interfering RNAs. Proceedings of National Academy of Sciences, 100, 2014-2018.
14. Gitlin, L., Karelsky, S., & Andino, R. (2002). Short interfering RNA confers intracellular antiviral immunity in human cells. Nature, 418, 430-434.
15. Jacque, J. M., Triques, K., & Stevenson, M. (2002). Modulation of HIV-1 replication by RNA interference. Nature, 418, 435-438.
16. Ge, Q., McManus, M. T., Nguyen, T., et al. (2003). RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription. Proceedings of National Academy of Sciences, 100, 2718-2723.
17. McCaffrey, A. P., Nakai, H., Pandey, K., et al. (2003). Inhibition of hepatitis B virus in mice by RNA interference. Nature Biotechnology, 21, 639-644.
18. Moore, M. D., McGarvey, M. J., Russell, R. A., et al. (2005). Stable inhibition of hepatitis B virus proteins by small interfering RNA expressed from viral vectors. The Journal of Gene Medicine, 7, 918-925.
19. Morrissey, D. V., Blanchard, K., Shaw, L., et al. (2005). Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication. Hepatology, 41, 1349-1356.
20. Uprichard, S. L., Boyd, B., Althage, A., et al. (2005). Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs. Proceedings of National Academy of Sciences, 102, 773-778.
21. Morrissey, D. V., Lockridge, J. A., Shaw, L., et al. (2005). Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nature Biotechnology, 23, 1002-1007.
22. Li, G. Q., Gu, H. X., Li, D., et al. (2007). Inhibition of Hepatitis B virus cccDNA replication by siRNA. Biochemical and Biophysical Research Communications, 2, 404-408.
23. Fu, L., Wu, X., Kong, Y., et al. (1997). Regulation of HBV gene expression by core promoter and its upstream sequence. Chinese Journal of Virology, 13, 215-223.
24. Liu, F., Song, Y., & Liu, D. (1999). Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Therapy, 7, 1258-1266.
25. Eckhardt, S. G., Milich, D. R., & McLachlan, A. (1991). Hepatitis B virus core protein has two nuclear localization sequences in the argininerich carboxyl terminus. Journal of Virology, 65, 575-582.